世界の細胞・遺伝子治療市場は、予測期間中に約20.15 %のCAGRで推移し、2022年から2026年の間に99億7,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、慢性疾患の増加、特効薬指定の増加、細胞および遺伝子ベースの研究に対する資金提供の増加によって牽引されています。
本調査では、今後数年間の細胞・遺伝子治療市場の成長を牽引する主要な理由の一つとして、新興用途の医薬品開発への注目が高まっていることを挙げています。また、新興経済諸国における戦略的提携や急速な成長の可能性も、市場の大きな需要につながると考えられます。
TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な細胞・遺伝子治療市場ベンダーの詳細な分析を提供します
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Cell therapy - Market size and forecast 2021-2026
Exhibit 28: Chart on Cell therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Cell therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Cell therapy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Cell therapy - Year-over-year growth 2021-2026 (%)
5.4 Gene therapy - Market size and forecast 2021-2026
Exhibit 32: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Amgen Inc.
Exhibit 85: Amgen Inc. - Overview
Exhibit 86: Amgen Inc. - Product / Service
Exhibit 87: Amgen Inc. - Key offerings
10.4 Biogen Inc.
Exhibit 88: Biogen Inc. - Overview
Exhibit 89: Biogen Inc. - Product / Service
Exhibit 90: Biogen Inc. - Key offerings
10.5 bluebird bio Inc.
Exhibit 91: bluebird bio Inc. - Overview
Exhibit 92: bluebird bio Inc. - Product / Service
Exhibit 93: bluebird bio Inc. - Key offerings
10.6 Bristol Myers Squibb Co.
Exhibit 94: Bristol Myers Squibb Co. - Overview
Exhibit 95: Bristol Myers Squibb Co. - Product / Service
Exhibit 96: Bristol Myers Squibb Co. - Key offerings
10.7 CORESTEM Inc.
Exhibit 97: CORESTEM Inc. - Overview
Exhibit 98: CORESTEM Inc. - Product / Service
Exhibit 99: CORESTEM Inc. - Key offerings
10.8 Dendreon Pharmaceuticals LLC.
Exhibit 100: Dendreon Pharmaceuticals LLC. - Overview
Exhibit 101: Dendreon Pharmaceuticals LLC. - Product / Service
Exhibit 102: Dendreon Pharmaceuticals LLC. - Key offerings
10.9 JCR Pharmaceticals Co. Ltd.
Exhibit 103: JCR Pharmaceticals Co. Ltd. - Overview
Exhibit 104: JCR Pharmaceticals Co. Ltd. - Product / Service
Exhibit 105: JCR Pharmaceticals Co. Ltd. - Key offerings
10.10 Novartis AG
Exhibit 106: Novartis AG - Overview
Exhibit 107: Novartis AG - Business segments
Exhibit 108: Novartis AG - Key offerings
Exhibit 109: Novartis AG - Segment focus
10.11 Pfizer Inc.
Exhibit 110: Pfizer Inc. - Overview
Exhibit 111: Pfizer Inc. - Product / Service
Exhibit 112: Pfizer Inc. - Key news
Exhibit 113: Pfizer Inc. - Key offerings
10.12 Vericel Corp.
Exhibit 114: Vericel Corp. - Overview
Exhibit 115: Vericel Corp. - Business segments
Exhibit 116: Vericel Corp. - Key news
Exhibit 117: Vericel Corp. - Key offerings
Exhibit 118: Vericel Corp. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 119: Inclusions checklist
Exhibit 120: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 121: Currency conversion rates for US$
11.4 Research methodology
Exhibit 122: Research methodology
Exhibit 123: Validation techniques employed for market sizing
Exhibit 124: Information sources
11.5 List of abbreviations
Exhibit 125: List of abbreviations
health: Includes veterinary drugs (excluded from the scope of the report)
